Newborn response to cationic amphiphilic drugs.
Administration of various cationic amphiphilic drugs in utero results in induction of a phospholipid storage disorder in many tissues, particularly in lungs. In addition to the phospholipidosis in utero, drug exposure results in toxicity to the offspring; newborn rats die within 48 h of birth. Although drug-induced pulmonary pathological changes appear to be involved in the observed mortality, this relationship remains unclear. In contrast to mammals, administration of cationic amphiphilic drugs to the chick embryo seems not to induce phospholipid storage in the tissues examined. Treatment of newborn rats directly with these drugs also induces phospholipidosis in several tissues including lung and kidney; however, mortality does not occur. Concurrent administration of phenobarbital and chlorphentermine reduces or prevents amphiphilic drug-induced phospholipid storage in newborn rat lung and kidney. Modification of chlorphentermine actions by phenobarbital may be caused by alterations in amphiphilic drug excretion, metabolism, and catabolic phospholipase activity. Evidence thus indicates that regardless of age, animals appear susceptible to the effects of cationic amphiphilic drugs; however, species and tissues examined, as well as specific drug administration, play an important role in the observed qualitative and quantitative responses.
Kacew
S
S
Reasor
M J
MJ
D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism*; D002745:Chlorphentermine / Q000633:toxicity*; D003907:Dexamethasone / Q000494:pharmacology; D004347:Drug Interactions; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005839:Gentamicins / Q000633:toxicity; D008064:Lipidoses / Q000139:chemically induced; D008168:Lung / Q000187:drug effects; D010634:Phenobarbital / Q000633:toxicity; D010645:Phentermine / Q000031:analogs & derivatives*; D010743:Phospholipids / Q000378:metabolism; D010879:Piperazines / Q000633:toxicity; D011247:Pregnancy; D014308:Triparanol / Q000633:toxicity; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride / Q000633:toxicity
D005839:Gentamicins; D010743:Phospholipids; D010879:Piperazines; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride; D014308:Triparanol; D003907:Dexamethasone; D010645:Phentermine; D002745:Chlorphentermine; D010634:Phenobarbital